Conjugated Lithocholic Acid Activates Hepatic TGR5 to Promote Lipotoxicity and MASLD‐MASH Transition by Disrupting Carnitine Biosynthesis
Advanced Science · 2025-05 · 12 (20)
DOI: 10.1002/advs.202410602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.05.2025. Verfasst von Senlin Lian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lab Medicine, The First Affiliated Hospital of Anhui Medical University. MOE Innovation Center for Basic Research in Tumor Immunotherap…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Carnitine, Lithocholic Acid, Liver. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Fund for Distinguished Young Scholars of Anhui Province, National Natural Science Foundation of China, The Key program of Taizhou School of Clinical Medicine, Nanjing Medical University.
Abstract (Originalsprache)
Conjugated lithocholic acid (LCA) plays a critical role in the development of metabolic dysfunction‐associated steatotic liver disease (MASLD). In this process, hepatocyte inflammation‐caused upregulation of its receptor, Takeda G protein‐coupled receptor 5 (TGR5) is a crucial factor. Serum bile acid profiling shows an increase in conjugated LCA, which correlates with disease severity. Depletion of Gpbar1 in hepatocytes significantly protects against the progression from MASLD to metabolic dysfunction‐associated steatohepatitis (MASH) that is related to conjugated LCA. In vivo and in vitro experiments indicate that TGR5 activation in hepatocytes promotes lipotoxicity‐induced cell death and inflammation by suppressing de novo carnitine biosynthesis. Mechanistically, TGR5 binding to CD36 facilitates E3 ubiquitin ligase TRIM21 recruitment, leading to the degradation of BBOX1, a crucial enzyme in de novo carnitine biosynthesis. Targeting TGR5 therapeutically can restore carnitine biosynthesis, which may offer a potent strategy to prevent or reverse the transition from MASLD to MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Lab Medicine, The First Affiliated Hospital of Anhui Medical University. MOE Innovation Center for Basic Research in Tumor Immunotherapy, and Anhui Province Key Laboratory of Tumor Immune Microenvironment…
- Medical School of Nanjing University, Nanjing, Jiangsu Province, 210993, China.
- Department of Gastroenterology, Affiliated Nanjing Drum Tower Hospital, and Medical School of Nanjing University, Nanjing, Jiangsu Province, 210008, China.
- NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, China.
- The Children's Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, 310052, China.
- Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.
ORCID-Profile: Runqiu Jiang
Förderung
- Science Fund for Distinguished Young Scholars of Anhui Province
- National Natural Science Foundation of China
- The Key program of Taizhou School of Clinical Medicine, Nanjing Medical University
Zitieren
APA
Lian, S., Lu, M., Jiajing, L., Zhang, B., Fang, Y., Wang, X., Zheng, M., Ni, Y., Xu, G., Yang, Y., & Jiang, R. (2025). Conjugated Lithocholic Acid Activates Hepatic TGR5 to Promote Lipotoxicity and MASLD‐MASH Transition by Disrupting Carnitine Biosynthesis. Advanced Science, 12(20). https://doi.org/10.1002/advs.202410602
Vancouver
Lian S, Lu M, Jiajing L, Zhang B, Fang Y, Wang X, et al. Conjugated Lithocholic Acid Activates Hepatic TGR5 to Promote Lipotoxicity and MASLD‐MASH Transition by Disrupting Carnitine Biosynthesis. Advanced Science. 2025;12(20). doi:10.1002/advs.202410602
BibTeX
@article{Lian2025,
author = {Lian, Senlin and Lu, Meixi and Jiajing, Luo and Zhang, Bin and Fang, Yi and Wang, Xuran and Zheng, Minghua and Ni, Yan and Xu, Guifang and Yang, Yonglin and Jiang, Runqiu},
title = {Conjugated Lithocholic Acid Activates Hepatic TGR5 to Promote Lipotoxicity and MASLD‐MASH Transition by Disrupting Carnitine Biosynthesis},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {20},
doi = {10.1002/advs.202410602}
}
EUVIMED